SEB Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
SEB Asset Management's BMRN Position: Q3 2026 in Review
SEB Asset Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 29% in Q3 2026, selling an estimated $7.47M and leaving 293,461 shares worth $17.6M. The position accounts for 0.07% of the portfolio, ranked #237.
SEB Asset Management first reported a position in BMRN in Q1 2026 and has held it in 3 quarters since. The position peaked at $23.6M in Q2 2026. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- SEB Asset Management held 293,461 shares of BioMarin Pharmaceuticals worth $17.6M as of Q3 2026.
- SEB Asset Management sold 118,689 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $7.47M.
- BioMarin Pharmaceuticals made up 0.07% of SEB Asset Management's portfolio in Q3 2026, its #237 holding.
- SEB Asset Management first reported a position in BioMarin Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's BioMarin Pharmaceuticals position peaked at $23.6M in Q2 2026.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.